Axogen, Inc. Announces Positive Topline Results from Phase II RECON(SM) Study for Avance^® Nerve Graft

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced topline results from its RECON Clinical Study comparing Avance Nerve Graft to conduits in digital nerve injuries.